Emmanuel Larbi

1.2k total citations
55 papers, 975 citations indexed

About

Emmanuel Larbi is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Emmanuel Larbi has authored 55 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Emmanuel Larbi's work include Acute Ischemic Stroke Management (8 papers), Sodium Intake and Health (4 papers) and Research on Leishmaniasis Studies (4 papers). Emmanuel Larbi is often cited by papers focused on Acute Ischemic Stroke Management (8 papers), Sodium Intake and Health (4 papers) and Research on Leishmaniasis Studies (4 papers). Emmanuel Larbi collaborates with scholars based in Saudi Arabia, United States and Ghana. Emmanuel Larbi's co-authors include Adnan Awada, S. Al Rajeh, J. O. M. Pobee, Abdullah M. Al‐Rubaish, Hussein Al-Freihi, Ibrahim Saeed, O. Bademosi, Maha Abdel Hadi, D. W. Belcher and Abdullah A. Yousef and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Emmanuel Larbi

54 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emmanuel Larbi Saudi Arabia 17 285 221 219 149 109 55 975
Damien Barraud France 18 592 2.1× 146 0.7× 120 0.5× 167 1.1× 164 1.5× 28 1.4k
George P. Giacoia United States 21 140 0.5× 143 0.6× 86 0.4× 411 2.8× 82 0.8× 78 1.4k
Ignacio Ayestarán Spain 17 341 1.2× 103 0.5× 117 0.5× 265 1.8× 127 1.2× 57 1.0k
Reha Erkoç Türkiye 18 161 0.6× 71 0.3× 153 0.7× 141 0.9× 77 0.7× 82 1.0k
Daniela Catalano Italy 18 495 1.7× 111 0.5× 135 0.6× 139 0.9× 62 0.6× 54 1.1k
Peter Walger Germany 16 205 0.7× 71 0.3× 313 1.4× 91 0.6× 54 0.5× 43 967
Sidney Tessler United States 13 586 2.1× 71 0.3× 228 1.0× 294 2.0× 100 0.9× 43 1.4k
Tomohito Sadahiro Japan 23 546 1.9× 134 0.6× 96 0.4× 143 1.0× 76 0.7× 48 1.4k
Ana Rodríguez–Carmona Spain 22 166 0.6× 116 0.5× 79 0.4× 205 1.4× 141 1.3× 77 1.6k
Daliana Peres Bota Belgium 10 670 2.4× 152 0.7× 158 0.7× 161 1.1× 66 0.6× 12 1.2k

Countries citing papers authored by Emmanuel Larbi

Since Specialization
Citations

This map shows the geographic impact of Emmanuel Larbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Larbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Larbi more than expected).

Fields of papers citing papers by Emmanuel Larbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Larbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Larbi. The network helps show where Emmanuel Larbi may publish in the future.

Co-authorship network of co-authors of Emmanuel Larbi

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Larbi. A scholar is included among the top collaborators of Emmanuel Larbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Larbi. Emmanuel Larbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larbi, Emmanuel, et al.. (2025). Inaccurate labelling practices in probiotic products: A regulatory shortfall in Accra, Ghana. PLoS ONE. 20(5). e0322194–e0322194. 4 indexed citations
2.
Kovel, Carolien G. F. de, Flip Mulder, Jessica van Setten, et al.. (2016). Exome-Wide Association Analysis of Coronary Artery Disease in the Kingdom of Saudi Arabia Population. PLoS ONE. 11(2). e0146502–e0146502. 5 indexed citations
3.
Al‐Ali, Amein K., et al.. (2013). β 2 -adrenergic receptor gene polymorphisms in normal and in patients with myocardial infarction in the eastern province of Saudi Arabia. SHILAP Revista de lepidopterología. 1(1). 25–25. 1 indexed citations
4.
Awada, Adnan, et al.. (2009). Hematological values and their assessment as risk factor in Saudi patients with stroke. Acta Neurologica Scandinavica. 89(6). 439–445. 5 indexed citations
5.
Al‐Ali, Amein K., et al.. (2008). Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis. International Journal of Biomedical Science. 175–178. 2 indexed citations
6.
Al‐Ali, Amein K., et al.. (2008). Increased Prevalence of Glycoprotein IIb/IIIa Leu 33 Pro Polymorphism in End Stage Renal Disease Patients on Hemodialysis.. PubMed. 4(3). 175–8. 3 indexed citations
7.
Hadi, Maha Abdel, et al.. (2001). Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagnostic Microbiology and Infectious Disease. 40(1-2). 1–4. 104 indexed citations
8.
Al-Muhanna, Fahd A, et al.. (1999). Disease profile, complications and outcome in patients on maintenance haemodialysis at King Faisal University Hospital, Saudi Arabia.. PubMed. 76(12). 664–7. 9 indexed citations
9.
Larbi, Emmanuel, et al.. (1998). Stroke Register: Experience from the Eastern Province of Saudi Arabia. Cerebrovascular Diseases. 8(2). 86–89. 92 indexed citations
10.
Ogunniyi, A, et al.. (1998). Risk factors of stroke at high and low altitude areas in Saudi Arabia.. PubMed. 29(2). 173–7. 26 indexed citations
11.
Al‐Quorain, Abdulaziz, et al.. (1997). Tuberculous Peritonitis in Children: Report of Two Cases and Literature Review. Journal of Pediatric Gastroenterology and Nutrition. 24(2). 222–225. 8 indexed citations
12.
Al‐Quorain, Abdulaziz, et al.. (1997). Tuberculous Peritonitis in Children: Report of Two Cases and Literature Review. Journal of Pediatric Gastroenterology and Nutrition. 24(2). 222–225. 1 indexed citations
13.
Rajeh, S. Al, et al.. (1995). Angiographic patterns of carotid ischemic cerebrovascular disease in Saudi Arabia. Journal of the Neurological Sciences. 134(1-2). 167–170. 4 indexed citations
14.
Larbi, Emmanuel, et al.. (1995). A Randomized, Double-Blind, Clinical Trial of Topical Clotrimazole Versus Miconazole for Treatment of Cutaneous Leishmaniasis in the Eastern Province of Saudi Arabia. American Journal of Tropical Medicine and Hygiene. 52(2). 166–168. 40 indexed citations
15.
Al‐Quorain, Abdulaziz, et al.. (1995). A Double-Blind, Randomized, Placebo-Controlled Trial of Cisapride in Saudi Arabs with Functional Dyspepsia. Scandinavian Journal of Gastroenterology. 30(6). 531–534. 27 indexed citations
16.
Awada, Adnan, et al.. (1992). [Cerebrovascular disorders in young adults in Saudi Arabia. A study of 136 cases].. PubMed. 148(8-9). 550–4. 5 indexed citations
17.
Al‐Rajeh, Saad, Emmanuel Larbi, O. Bademosi, et al.. (1991). Pattern and ethnic variations in stroke in Saudi Arabia. Journal of the Neurological Sciences. 102(1). 112–118. 24 indexed citations
18.
Al‐Rajeh, Saad, et al.. (1991). Stroke in a Tertiary Hospital in Saudi Arabia: A Study of 372 Cases. European Neurology. 31(4). 251–256. 38 indexed citations
19.
Larbi, Emmanuel & Eleanor Zaimis. (1970). The effect of the chronic administration of clonidine (St 155) on vascular smooth muscle (T).. British Journal of Pharmacology. 39(1).
20.
James, IM, Emmanuel Larbi, & Eleanor Zaimis. (1970). The effect of the acute intravenous administration clonidine (St 155) on cerebral blood flow in man.. PubMed. 39(1). 198P–199P. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026